JAMES BUCKNER: Open Payments
NPI 1407030349 · MARSHFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$210 in 11 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $22 · 2025 $210
Food & beverage: $210
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $47 |
| Viatris Specialty LLC | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Astellas Pharma US Inc | 1 | $21 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| Exact Sciences Corporation | 1 | $15 |
Products named: Ozempic, YUPELRI, CAPLYTA, Veozah, JOURNAVX, BREZTRI, Cologuard Collection Kit, AIRSUPRA.
Industry payments across MO — which companies pay providers there.
